The Monkey Pox Vaccine has been around since 197 Developed in the United States, the vaccine was initially created to protect against the virus that causes the smallpox virus. Over the decades, the vaccine has been continually updated and improved to provide immunization to humans against the highly contagious virus.
For example, in 2016, the World Health Organization recommended its use for persons over the age of 9 months and later added the appropriate dosages for children between 5 and 17 years of age. Since its development, the vaccine has been officially recommended for use in more than 40 countries and is especially highly recommended for a high risk exposure situation.